Two Sigma Advisers’s Cerenome, Inc. Common Stock CNSY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-86
Closed -$9.31K 2604
2023
Q1
$9.31K Sell
86
-1
-1% -$135 ﹤0.01% 2545
2022
Q4
$10.4K Sell
87
-26
-23% -$4.14K ﹤0.01% 2458
2022
Q3
$19K Sell
113
-19
-14% -$4.24K ﹤0.01% 2444
2022
Q2
$27K Sell
132
-79
-37% -$19.7K ﹤0.01% 2529
2022
Q1
$79K Sell
211
-493
-70% -$188K ﹤0.01% 2536
2021
Q4
$277K Buy
704
+540
+329% +$311K ﹤0.01% 2168
2021
Q3
$117K Sell
164
-304
-65% -$232K ﹤0.01% 2311
2021
Q2
$449K Buy
468
+305
+187% +$276K ﹤0.01% 1982
2021
Q1
$147K Buy
163
+97
+147% +$98.3K ﹤0.01% 2396
2020
Q4
$50K Buy
+66
New +$56.4K ﹤0.01% 2317
2015
Q1
Hold
0
-$5K 2295
2014
Q4
Hold
0
2393

Other funds holding CNSY

Two Sigma Advisers's CNSY Position: Q2 2023 in Review

Two Sigma Advisers sold out of Cerenome, Inc. Common Stock (CNSY) in Q2 2023, closing a stake of 86 shares — an estimated $9.31K sold.

Two Sigma Advisers first reported a position in CNSY in Q4 2020 and held it in 10 quarters. The position peaked at $449K in Q2 2021. 6 funds tracked by Wall St. Rank hold CNSY as of Q2 2023.

  • Two Sigma Advisers reported no remaining Cerenome, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 86 Cerenome, Inc. Common Stock shares in Q2 2023, an estimated $9.31K.
  • Two Sigma Advisers first reported a position in Cerenome, Inc. Common Stock in Q4 2020 and held it in 10 quarters.
  • Two Sigma Advisers's Cerenome, Inc. Common Stock position peaked at $449K in Q2 2021.
  • 6 funds tracked by Wall St. Rank held Cerenome, Inc. Common Stock as of Q2 2023.

Based on Two Sigma Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.